4SC Past Earnings Performance

Past criteria checks 0/6

4SC has been growing earnings at an average annual rate of 12.8%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 18.8% per year.

Key information

12.8%

Earnings growth rate

22.5%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate-18.8%
Return on equity-687.0%
Net Margin-2,097.2%
Next Earnings Update28 Mar 2025

Recent past performance updates

Recent updates

Is 4SC (FRA:VSC) Using Debt Sensibly?

Aug 14
Is 4SC (FRA:VSC) Using Debt Sensibly?

Does 4SC (FRA:VSC) Have A Healthy Balance Sheet?

Apr 03
Does 4SC (FRA:VSC) Have A Healthy Balance Sheet?

We Think 4SC (FRA:VSC) Needs To Drive Business Growth Carefully

Apr 28
We Think 4SC (FRA:VSC) Needs To Drive Business Growth Carefully

Revenue & Expenses Breakdown

How 4SC makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:VSC Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-820
31 Mar 240-820
31 Dec 230-820
30 Sep 230-820
30 Jun 230-820
31 Mar 230-1130
31 Dec 220-1440
30 Sep 220-1940
30 Jun 220-2350
31 Mar 227-1650
31 Dec 2114-1050
30 Sep 2115-845
30 Jun 2116-749
31 Mar 219-13314
31 Dec 202-19318
30 Sep 201-19317
30 Jun 200-19316
31 Mar 201-16315
31 Dec 192-14314
30 Sep 192-15315
30 Jun 192-17316
31 Mar 193-17317
31 Dec 184-18318
30 Sep 186-15317
30 Jun 187-12315
31 Mar 186-11313
31 Dec 174-11311
30 Jun 172-1039
31 Mar 172-11410
31 Dec 162-11411
30 Jun 161-1149
31 Mar 161-1038
31 Dec 152-836
30 Sep 154-1047
30 Jun 156-1048
31 Mar 158-948
31 Dec 147-1049
30 Sep 147-948
30 Jun 147-839
31 Mar 146-10310

Quality Earnings: VSC is currently unprofitable.

Growing Profit Margin: VSC is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VSC is unprofitable, but has reduced losses over the past 5 years at a rate of 12.8% per year.

Accelerating Growth: Unable to compare VSC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VSC is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).


Return on Equity

High ROE: VSC has a negative Return on Equity (-686.95%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 19:10
End of Day Share Price 2025/01/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

4SC AG is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Linda PomeroyEdison Investment Research
null nullgoetzpartners securities Limited
Sachin SoniKempen & Co. NV